Research Scientist-PBPK Modeler (To apply: http://bit.ly/32999_GD)
At Lilly, we unite caring with discovery to make life better for people around the world. We are a global healthcare leader headquartered in Indianapolis, Indiana. Our 39,000 employees around the world work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to our communities through philanthropy and volunteerism. We give our best effort to our work, and we put people first. We're looking for people who are determined to make life better for people around the world. The Mechanistic Pharmacokinetics group within The Department of Drug Disposition (ADME) is searching for a PBPK modeler. The Department of Drug Disposition is a multidisciplinary group, utilizing in vitro, in vivo, and in silico approaches to study the pharmacokinetics, absorption, and disposition of new chemical entities. The scientist will function as a PBPK modeler, part of a team responsible for providing innovative mechanistic PK models to drive and influence decision making on drug Discovery and Development project teams. Some of the key responsibilities may include: * Evaluate and apply innovative PBPK/MPK approaches to translate and predict human PK. * Use modeling as a tool to help generate hypotheses, design better studies, inform clinical plans and support registration. * Peer review modeling work from colleagues as appropriate, ensuring high quality standards. * Provide expert modeling consultancy, training and support to others within ADME and within the larger R&D organization * Liaise with ADME, PK/PD and Clinical Pharmacology representatives to communicate the assumptions, limitations, meaning and impact of mechanistic PK models. * Promote and increase the reputation of mechanistic modeling approaches both internally within R&D and externally including regulatory agencies * Provide training and coaching to scientists within the department to increase mechanistic thinking and the application and impact of mechanistic modelling. * Build a strong external network in the field of mechanistic modeling (e.g. academia, consortia) and keep up to date with emerging literature and science in the area Basic Qualifications * Ph.D. in PBPK modeling, Pharmacokinetics or a related field or MS and 7 years or BS and 10 years or of applicable experience in PBPK, Pharmacokinetics modeling or related field Additional Skills/Preferences * Hands-on experience in modeling software like SimCYP, GastroPlus, MatLab/Simbiology, NONMEM etc. is required. * Must have a thorough understanding of pharmacokinetics, ADME and PBPK modeling and ability to communicate theory and concepts clearly * Understanding of the implications of PBPK modeling and drug-drug interaction simulations for drug labelling and the international regulatory guidance pertaining to those activities * Collaborative behaviors to build and maintain relationships with R&D customers and the wider modeling community. * Ability to influence, negotiate and communicate with both internal and external stake holders Limited travel required for conferences, external reviews, and regulatory meetings. Lilly is an EEO/Affirmative Action Employer and does not discriminate on the basis of age, race, color, religion, gender, sexual orientation, gender identity, gender expression, national origin, protected veteran status, disability or any other legally protected status. Gemma L. Dickinson Director, Drug Disposition Eli Lilly and Company Lilly Corporate Center, Indianapolis IN 46285 U.S.A. +1 317.209.5500 (mobile) dickinson_gemma_lou...@lilly.com<mailto:emailaddr...@lilly.com> | www.lilly.com<http://www.lilly.com/> [LillyLogo_EmailSig2.jpg] CONFIDENTIALITY NOTICE: This email message (including all attachments) is for the sole use of the intended recipient(s) and may contain confidential information. Any unauthorized review, use, disclosure, copying or distribution is strictly prohibited. If you are not the intended recipient, please contact the sender by reply email and destroy all copies of the original message.
